Bain Capital Life Sciences Investors, Llc Kyverna Therapeutics, Inc. (KYTX) insider trading activity

KYTX Quotes by TradingView

Bain Capital Life Sciences Investors, LLC Transaction History

Date Transaction Value Shares Traded Form
Feb 12 2024
BUY
Open market or private purchase
$9,900,000 $22.0 p/Share
450,000
Feb 12 2024
BUY
Conversion of derivative security
-
2,713,868

Also insider at

MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
> 10% Shareholder
DRNA
Dicerna Pharmaceuticals Inc
> 10% Shareholder
REPL
Replimune Group, Inc. Healthcare
> 10% Shareholder
SWTX
SpringWorks Therapeutics, Inc. Healthcare
> 10% Shareholder
ARQT
Arcutis Biotherapeutics, Inc. Healthcare
> 10% Shareholder
ANNX
Annexon, Inc. Healthcare
> 10% Shareholder
APTX
Aptinyx Inc. Healthcare
> 10% Shareholder
RPID
RAPID MICRO BIOSYSTEMS, INC. Healthcare
> 10% Shareholder
XLO
Xilio Therapeutics, Inc. Healthcare
> 10% Shareholder
SLDB
Solid Biosciences Inc. Healthcare
NAMS
NewAmsterdam Pharma Co N.V.
BCL

Bain Capital Life Sciences Investors, LLC

Boston, MA

Track Institutional and Insider Activities on KYTX

Follow Kyverna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYTX shares.

Notify only if

Insider Trading

Get notified when an Kyverna Therapeutics, Inc. insider buys or sells KYTX shares.

Notify only if

News

Receive news related to Kyverna Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYTX